Document is current
Any future updates will be listed below
-
Authors
De Luca, Daniele http://orcid.org/0000-0002-3846-4834
Cogo, Paola
Kneyber, Martin C.
Biban, Paolo
Semple, Malcolm Grace
Perez-Gil, Jesus
Conti, Giorgio
Tissieres, Pierre
Rimensberger, Peter C.
- License Information
-
More Information
Article History
Received: 25 December 2020
Accepted: 4 February 2021
First Online: 22 February 2021
Ethical approval and consent to participate
: Not applicable.
: Not applicable.
: DDL received research and educational grants from Chiesi Pharmaceuticals spa and ABBVIE inc. He served as lecturer for, Chiesi Pharmaceuticals spa, ABBVIE inc and Getinge, and finally, has been a member of advisory boards for Chiesi Pharmaceuticals spa, ABBVIE inc, Airway Therapeutics and a consultant for OPHIREX inc. PC received research and educational grants and has been a member of advisory board for Chiesi Pharmaceuticals spa. MCK received research and educational grants from Vyaire. He served as a consultant and lecturer for Vyaire. Finally, MK has received research funding from The Royal Dutch Academy of Sciences, ZonMW, NHLBI/NIH and Stichting Vrienden Beatrix Kinderziekenhuis. PB served as lecturer for Chiesi Pharmaceutical spa and Getinge. He received research grants from and has been a member of advisory board for Chiesi Pharmaceuticals spa. MGS has been a member of advisory board for Chiesi Pharmaceuticals spa. JPG received research grants and assistance and/or served as consultant for Chiesi Pharmaceuticals spa, CENSA and Airway Therapeutics. GC served as lecturer and advisory board member for Chiesi Pharmaceuticals spa. PT has received research grants from and has been an advisory board member for Chiesi Pharmaceuticals spa. He received research grant from BioMérieux Inc. and has been serving as consultant for Sedana Inc., Baxter Acute Therapies Inc., and Bristol Myers Squib Inc. PCR has no conflict of interest to declare.
